[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567750":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":38,"responsibleParty":52,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":69,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":75,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Chang Gung Memorial Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"cancer for CTC culture",null,"a thrombosis patient with cancer .",[13],"Procedure: CTCs\u002FCTMs culture",{"label":15,"type":10,"description":16,"interventionNames":17},"health for CTC culture","a thrombosis patient without cancer",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"PROCEDURE","CTCs\u002FCTMs culture","Collect the thrombosis from participants underwent catheter-based thrombectomy.To characterized by cancer-specific surface markers successfully and identify within the culture",[9,15],[25],{"name":26,"affiliation":27,"role":28},"Hsin-Fu Lee, PhD","New Taipei City TuCheng Hospital","STUDY_DIRECTOR",[30,34],{"name":26,"role":31,"phone":32,"phoneExt":10,"email":33},"CONTACT","0975366105","8805033@cgmh.org.tw",{"name":35,"role":31,"phone":36,"phoneExt":10,"email":37},"Chia-Hsun Hsieh, PhD","0975366137","wisdom5000@cgmh.org.tw",[39],{"facility":27,"status":40,"city":41,"state":10,"zip":10,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","New Taipei City","Taiwan","TW",{"type":45,"coordinates":46},"Point",[47,48],121.45703,25.06199,{"lat":48,"lon":47},[51],{"name":26,"role":31,"phone":10,"phoneExt":10,"email":10},{"type":53,"investigatorFullName":54,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Hsin-Fu Lee","Professor Attending Physicians","100567750","the-correlation-between-circulatory-tumor-cells-and-venous-thrombosis-100567750",false,"NCT06672250","The Correlation Between Circulatory Tumor Cells and Venous Thrombosis","Inclusion Criteria:\n\n1. age≧18\n2. participants (1)participants without cancer: without cancer in five years (2)participants with cancer:pathology reveal have malignant tumor\n3. patients who underwent catheter-based thrombectomy\n4. agree do the thrombectomy\n\nExclusion Criteria:\n\n1. participants without cancer (1).shock (2).severe sepsis (3).with cancer in five years\n2. participants with cancer (1).shock (2).severe sepsis",true,"ALL","18 Years","80 Years",{"count":67,"type":68},120,"ESTIMATED","1 Day","OBSERVATIONAL","Research indicates a strong correlation between cancer and thrombosis, with approximately 20% of blood clots in the U.S. being cancer-related, according to CDC data. Cancer patients face a 4-7 times higher risk of thrombosis compared to non-cancer individuals. Certain cancer treatments, such as chemotherapy and targeted therapy, elevate the likelihood of venous thromboembolism (VTE). Cancer patients with VTE exhibit a significantly higher hazard ratio (H.R.) of 3.4 compared to those without VTE.\n\nThis study aims to explore three main topics: (1) Comparing the differences and similarities of leukocyte populations between cancer-associated thrombosis (CAT) and venous thromboembolism (VTE). (2) Characterizing the factors contributing to increased incidence of cancer-associated thrombosis (CAT), with the hypothesis that circulating tumor microemboli (CTM) may express more thrombosis-related proteins than CTCs. (3) Understanding the effects of aspirin or NOACs on cancer-associated thrombosis and CTM formation.",[73,74],"Tumor Cells, Circulating","Venous Thrombosis",[76,77,78,79,80],"Cancer","Thrombosis","Venous thromboembolism","Circulating tumor cells","Endovascular therapy","2025-09-19",{"date":83,"type":84},"2025-09-24","ACTUAL",{"date":86,"type":84},"2024-05-28",{"date":88,"type":68},"2027-04-30",{"name":5,"class":6},1]